Muhlenkamp & Co’s Affimed AFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding AFMD
NMC
BCPEM
NLVP
TCM
KCM
TI
SM
BBA
Muhlenkamp & Co's AFMD Position: Q1 2018 in Review
Muhlenkamp & Co sold out of Affimed (AFMD) in Q1 2018, closing a stake of 6,100 shares — an estimated $79K sold.
Muhlenkamp & Co first reported a position in AFMD in Q3 2015 and held it in 10 quarters. The position peaked at $203K in Q3 2016. 42 funds tracked by Wall St. Rank hold AFMD as of Q1 2018.
- Muhlenkamp & Co reported no remaining Affimed position as of Q1 2018 after selling out during the quarter.
- Muhlenkamp & Co sold 6,100 Affimed shares in Q1 2018, an estimated $79K.
- Muhlenkamp & Co first reported a position in Affimed in Q3 2015 and held it in 10 quarters.
- Muhlenkamp & Co's Affimed position peaked at $203K in Q3 2016.
- 42 funds tracked by Wall St. Rank held Affimed as of Q1 2018.
Based on Muhlenkamp & Co's 13F filing for Q1 2018, filed 11 May 2018.